Skip to main content
PLOS Biology logoLink to PLOS Biology
. 2020 Dec 11;18(12):e3001032. doi: 10.1371/journal.pbio.3001032

Distinct populations of crypt-associated fibroblasts act as signaling hubs to control colon homeostasis

Michael David Brügger 1,#, Tomas Valenta 1,2,*,#, Hassan Fazilaty 1,#, George Hausmann 1, Konrad Basler 1,*
Editor: Emma Rawlins3
PMCID: PMC7758045  PMID: 33306673

Abstract

Despite recent progress in recognizing the importance of mesenchymal cells for the homeostasis of the intestinal system, the current picture of how these cells communicate with the associated epithelial layer remains unclear. To describe the relevant cell populations in an unbiased manner, we carried out a single-cell transcriptome analysis of the adult murine colon, producing a high-quality atlas of matched colonic epithelium and mesenchyme. We identify two crypt-associated colonic fibroblast populations that are demarcated by different strengths of platelet-derived growth factor receptor A (Pdgfra) expression. Crypt-bottom fibroblasts (CBFs), close to the intestinal stem cells, express low levels of Pdgfra and secrete canonical Wnt ligands, Wnt potentiators, and bone morphogenetic protein (Bmp) inhibitors. Crypt-top fibroblasts (CTFs) exhibit high Pdgfra levels and secrete noncanonical Wnts and Bmp ligands. While the Pdgfralow cells maintain intestinal stem cell proliferation, the Pdgfrahigh cells induce differentiation of the epithelial cells. Our findings enhance our understanding of the crosstalk between various colonic epithelial cells and their associated mesenchymal signaling hubs along the crypt axis—placing differential Pdgfra expression levels in the spotlight of intestinal fibroblast identity.


Despite the known importance of mesenchymal cells for the homeostasis of the intestinal system, how these cells communicate with the associated epithelial layer remains unclear. A single cell atlas of matched colonic epithelium and mesenchyme identifies two fibroblast populations that orchestrate maintenance and differentiation of colonic epithelial stem cells.

Introduction

The architecture of the colon is made up of diverse cell types, including undifferentiated and various differentiated epithelial cells whose fates are tightly programmed by signals from both the epithelium and the underlying mesenchyme. The intestinal mesenchyme displays great cellular heterogeneity, consisting, among others, of myofibroblasts, fibroblasts, smooth muscle, and endothelial cells [1]. It is an important player in intestinal homeostasis and partakes in the multitude of signaling pathways that are integral to the maintenance of epithelial stem cells, as well as their subsequent differentiation.

The exposure to a hostile environment and constant wear and tear requires the intestinal epithelium to replenish roughly every 5 to 7 days. The epithelial dynamics are driven by stem cells located at the bottom of the crypts in the small intestine and the colon [2]. Stem cell maintenance and proliferation requires multiple inputs from the surrounding microenvironment (the niche), such as Notch, epidermal growth factor (EGF), and Wnt signals [3]. These are provided by extra-epithelial cells or by the epithelium itself. We and several other groups showed that intestinal mesenchymal cells form the extra-epithelial, stem cell–supporting niche in the small intestine, and colon [49]. The subepithelial mesenchymal niche populations were defined by their ability to support the maintenance of intestinal epithelial stem cells (IESC) and secrete canonical Wnt ligands. However, the exact identity of these niche cells remained unclear since different, only partly overlapping, cell populations were described to act as the functional niche cells. They were differentially demarcated by platelet-derived growth factor receptor A (Pdgfra) [4], CD34 [5], Gli1 [6], Foxl1 [7], CD90 [8], and CD81 [9].

The advent of single-cell RNA sequencing (scRNAseq) has enabled researchers to investigate intestinal epithelial and mesenchymal cell heterogeneity with unprecedented resolution [1012]. However, the applied approaches were based on specific cell isolation protocols that enriched solely for epithelial cells or the mesenchymal cells, leading to potential bias in the identifiable cell populations. Crypt-associated fibroblasts are tightly connected to the intestinal epithelium, thus mechanical or enzymatic removal of the epithelium may result in loss of certain mesenchymal subpopulations or vice versa.

In order to refine our understanding of the identity and function of the mesenchymal niche cells and their secreted factors, we performed an unbiased single-cell transcriptome analysis of the adult murine colon, looking at both epithelial and mesenchymal parts. We identify most of the known epithelial cell types and uncover the presence of two functionally distinct fibroblast populations: crypt-top fibroblasts (CTFs) and crypt-bottom fibroblasts (CBFs). These are also present in the colon of healthy humans. CBFs are Pdgfralow cells, located at the bottom of the crypts in close proximity to the stem cells and secrete canonical Wnt ligands (Wnt2 and Wnt2b), Wnt-signaling-potentiators (Rspo3), and bone morphogenetic protein (Bmp) inhibitors (Grem1). CTFs are Pdgfrahigh cells, located at the top of the crypt and secrete noncanonical Wnt ligands (Wnt5a) and Bmp ligands (Bmp2/3/4/5/7), thereby inducing epithelial differentiation. Together, these two cell populations form the antagonistic gradients of canonical Wnt signaling and Bmp signaling required for the precise control of stem cell maintenance and epithelial differentiation.

Results

Unbiased single-cell profiling of murine colonic cells

To gain a deeper understanding of the heterogeneity and complexity of the colonic epithelium and mesenchyme, as well as the associated signaling networks, we performed scRNAseq of murine colonic tissue. We dissociated epithelial and mesenchymal fractions individually into single cells and used fluorescence-activated cell sorting (FACS) to further purify epithelial (EpCAM+, CD45−) and non-epithelial cells (EpCAM−, CD45−), while concurrently depleting lymphocytes (EpCAM−, CD45+) (Fig 1A and 1B). Overall, we observe a colonic cellular composition consisting of 91.2% epithelial cells and 8.8% of non-epithelial cells. In contrast to previous studies, we next pooled the sorted epithelial (EpCAM+, CD45−) and non-epithelial (EpCAM−, CD45−) cells originating from both isolation protocols at equal fractions (1:1, epithelial:non-epithelial) to avoid epithelial overrepresentation and obtain sufficient data to describe both epithelial and non-epithelial cells in their full spectrum. Following quality control, scRNAseq results in a combined dataset of 7,395 cells with a mean transcript count of 3,243 per cell. Graph-based clustering reveals 16 individual clusters, which can be classified into three major groups: Epithelium (Epcam+, Krt19+), stroma (Vim+, Col1a1+), and endothelium (Pecam1+) (Fig 1C, S1A Fig).

Fig 1. Unbiased analysis of murine colon landscape reveals complexity and heterogeneity of epithelial and mesenchymal cells.

Fig 1

(A) Schematic representation of a colonic crypt with surface markers used to sort epithelial (green: EpCAM+, CD45−) and mesenchymal/non-epithelial cells (red: EpCAM−, CD45−). (B) Flow cytometry analysis using EpCAM and CD45 on single-cell suspension of colonic epithelial (left, raw data: S2 Data) and mesenchymal cell isolation (right, raw data: S3 Data) prior to the sort. (C) Left: three major groups (epithelial, stromal, and endothelial) clustering into 16 distinct cluster revealed by UMAP analysis. Right: Epithelial cells show higher proliferative activity (cells in S-G2M) than non-epithelial cells (UMAP, single cells are colored according to their cluster annotation (left) or cell cycle phase (right)). (D) Characterization of cluster identity using relative expression of marker genes. (Dot plot, size, and color of the dot represent the percentage of cells which express the transcript and the average expression level within a cluster, respectively). EE, enteroendocrine; IESC, intestinal epithelial stem cell; TA, transit-amplifying cell; UMAP, Uniform Manifold Approximation and Projection.

We could annotate most known epithelial cell types within our dataset with the exception of tuft cells. This designation is based on a combination of published marker genes [10,11,13] (Fig 1D) and differentially expressed genes (S1B Fig). Clusters 11 and 5 represent IESC and transit-amplifying cells (TA), respectively, based on the expression of Lgr5, Axin2, and Mki67 (Fig 1D) in combination with their high proliferative activity (Fig 1C). Clusters 9 and 10 delineate the secretory lineage (Atoh1+), the former consisting of classic goblet cells (Muc2+) and the latter the recently described deep crypt secretory cells (Reg4+) [14]. Indeed, these cells appear to be mainly responsible for the activation of Notch signaling in intestinal stem cells as they express both ligands: Dll1 and Dll4 (S1D Fig) [15]. An absorptive lineage composed of clusters 6 and 8 (Guca2a+, Alpi+, Aldh1l1+) (Fig 1D, S1B Fig) consists of enterocytes strongly enriched for Gene Ontology (GO) terms such as “Generation of precursor metabolites and energy and “Anion transport” (S1C Fig). The absorptive and secretory cells express a variety of Egf family ligands (Egf, Tgfa, Areg, and Hbegf) and ephrins (Efnb1 and Efnb2) (S1D Fig). Finally, cluster 14 comprises enteroendocrine cells (Chga+, Chgb+, and Neurod1+) which express high levels of Ihh—the main hedgehog ligand secreted by the intestinal epithelium (S1D Fig) [16].

We observed four stromal clusters (clusters 1, 2, 3 and 4), which all express typical fibroblast markers, such as Vim and Col1a1. In addition, we found clusters 12 and 15, which are pericytes (Rgs5+) and glia (S100b+), respectively.

Taken together, these data represent a comprehensive, high-quality dataset of murine colonic cell diversity, comprised of matching epithelium and mesenchyme.

Characterization of crypt-associated fibroblasts

We next subset and reanalyzed the four stromal clusters (stromal 1 to 4, Fig 1C) to gain insight into distinct subpopulations of crypt-associated fibroblasts and their individual niche potential in more detail (Fig 2A). Cluster S4 cells are likely smooth muscle cells (SMCs) due to the expression of Acta2 and Myh11 (see Fig 2D) in combination with GO term enrichment for muscle cell-specific functions, e.g., “Regulation of skeletal muscle contraction by calcium ion signaling” and “Myofibril assembly” (S2A Fig). However, we cannot exclude that this cluster also contains myofibroblasts.

Fig 2. CTFs (Pdgfrahigh) and CBFs (Pdgfralow) mark distinct functional colonic mesenchymal cell populations that control stem cell proliferation and epithelial differentiation in the murine colon.

Fig 2

(A) Heterogeneity of colonic mesenchymal cells (UMAP plot of the reanalyzed stromal subset, single cells are colored according to cluster annotation). (B) Relative expression of niche marker genes (UMAP, single cells are colored according to transcript expression). (C) Pdgfra expression across stromal clusters (violin plot, raw data: S1A Data). (D) Relative expression of fibroblast identity marker genes (Vim, Col1a1, Acta2, and Myh11), secreted factors resulting in stem cell maintenance (Wnt2, Wnt2b, Rspo3, and Grem1) and secreted factors resulting in epithelial differentiation (Wnt5a, Bmp3, and Bmp7) (violin plots, raw data: S1B Data). (E) Wnt5a is expressed by CTFs at the top of the colonic crypts (single-molecule RNA in situ hybridization (Scale bar = 20 μm, 5μm (1,2)). (F) GO enrichment terms for CTFs. (G) Heatmap of genes that are differentially expressed among the mesenchymal clusters (0.95 quantile) show strong similarities between CBFs1 and CBFs2 and clear distinction of CTFs and SMC. Bmp, bone morphogenetic protein; CBF, crypt-bottom fibroblast; CTF, crypt-top fibroblasts; GO, Gene Ontology; Pdgfra, platelet-derived growth factor receptor A; SMC, smooth muscle cell; UMAP, Uniform Manifold Approximation and Projection.

We interrogated the expression of markers previously used to demarcate the cells of the murine stem cell niche (Fig 2B). The hedgehog transcription factor Gli1 [6] shows ubiquitous expression in all stromal clusters (S1 to S4). Cd34 [5] and Cd90 [8] display a strong enrichment in clusters S1 and S2. However, Cd90 is also expressed in SMC and Cd34 is additionally expressed in endothelial cells. Foxl1 [7,17] is expressed specifically in clusters S3 and S4. Interestingly, while Pdgfra [4] is expressed in clusters S1, S2, and S3, it displays a strong difference in transcript levels. Indeed, cluster S3 shows a high expression of Pdgfra and clusters S1 and S2 show a low expression of Pdgfra (Fig 2C). Due to differences in spatial localization of Pdgfra-positive cells in regards to the colonic crypt (see below, Fig 3B and 3C), we henceforth refer to cluster S3 as CTFs and to clusters S1 and S2 as CBFs (CBFs1 and CBFs2, respectively). In accordance with their localization at the bottom of the crypt in close proximity to the intestinal stem cells, CBFs express factors important for stem cell maintenance, such as canonical Wnt ligands (Wnt2 and Wnt2b), Wnt signaling potentiators (Rspo3), and Bmp signaling antagonists (Grem1) (Fig 2D, S2B Fig). In contrast, CTFs express factors resulting in the induction of epithelial differentiation, such as Bmp ligands (Bmp2, Bmp3, Bmp4, Bmp5, and Bmp7), noncanonical Wnt ligands (Wnt5a), and inhibitors of canonical Wnt signaling (Dkk3) (Fig 2D and 2E, S2B Fig).

Fig 3. CTFs (Pdgfrahigh) and CBFs (Pdgfralow) are localized in a distinct manner along the colonic crypt axis.

Fig 3

(A–C) Cryosections of Pdgfra-H2B-eGFP mice. (A) High Pdgfra protein expression correlates with the level of Pdgfra transcript in Pdgfra-H2B-eGFP reporter mouse line. (Red: Pdgfra protein, green: GFP, blue: DAPI) (Scale bar = 40 μm), (1,2) Insets of crypt top and crypt bottom respectively (Scale bar = 5 μm). (B) CTFs (Pdgfrahigh) are localized at the top of the colonic crypt, whereas CBFs (Pdgfralow) are at the bottom. (Red: EpCAM, green: GFP, blue: DAPI) (Scale bar = 40 μm). (3,4) Insets of crypt top and crypt bottom, respectively, arrowheads point out Pdgfrahigh (GFP high) cells and arrows point out Pdgfralow (GFP low) cells. (Scale bar = 5 μm) (C) Fluorescence intensity measurement of GFP positive nuclei. nBottom = 159, nTop = 100, **** = p < 0.0001 (Unpaired t test with Welch correction) (Raw data: S1C Data) (D) Flow cytometry analysis for GFP on mesenchymal cells isolated from Pdgfra-H2B-eGFP mice identifying GFP, GFP-low, and GFP-high cells (Raw data: S4 Data). (E) Relative mRNA expression of Pdgfra, Wnt2, Wnt2b, Wnt5a, Rspo3, and Grem1 in CTFs (GFP high) and CBFs (GFP low) isolated from Pdgfra-H2B-eGFP reporter mouse line. (RT-qPCR, normalized to Hprt expression levels, FC levels in CBFs set to 1) (Raw data: S1D Data). (F) CBFs1, CBFs2, and CTFs populations determined by scRNAseq from colonic Pdgfra-positive cells (Pdgfra-H2B-eGFP reporter mouse line). (UMAP, single cells are colored according to cluster annotation). (G) Stromal clusters from wt and Pdgfra+ colonic scRNAseq analysis display high similarity. (Spearman correlation). CBF, crypt-bottom fibroblast; CTF, crypt-top fibroblasts; FC, fold change; GFP, green fluorescent protein; Pdgfra, platelet-derived growth factor receptor A; RT-qPCR, quantitative reverse transcription PCR; scRNAseq, single-cell RNA sequencing; UMAP, Uniform Manifold Approximation and Projection; wt, wild-type.

GO term enrichment recapitulates the molecular difference between crypt-associated fibroblast populations, with CTFs showing an enrichment for Bmp signaling pathway”, “Focal adhesion,” and “Prostaglandin Synthesis and Regulation” (Fig 2F), while CBFs show enrichment for terms such as “response to vascular endothelial growth factor signaling” and “regulation of extracellular matrix” (S2C and S2D Fig).

In sum, the analysis of differentially expressed genes exposes a high similarity in marker expression between the clusters CBFs1 and CBFs2 and a clear demarcation of CTFs and SMC (Fig 2G). However, we find interesting smaller differences between CBFs1 and CBFs2. CBFs1 (Fig 2G) show higher, but not exclusive, expression of the canonical Wnt ligands Wnt2 and Wnt2b (S3B Fig). In addition, they express Igfbp3, Igfbp5, Adam23, and Edil1 (Fig 2G), pointing toward potent integrin/extracellular signal-regulated kinase (ERK) signaling regulation [18]. CBFs2 (Fig 2G) show higher, but not exclusive, expression of the Bmp antagonist Gremlin 1 and the marker Cd81 (Fig 2G, S3B Fig), displaying high similarity to the recently described small intestinal trophocytes [9].

Furthermore, we employed the CellphoneDB [19] algorithm to infer possible communication (ligand–receptor interactions) between CBFs1, CBFs2, CTFs, and epithelial cells (S3A Fig). We were able to confirm expected crosstalk between populations, such as Wnt5a (from CTFs) potentially signaling to the noncanonical Wnt receptors Ror1 (expressed in cells of cluster Enterocyte 1) and Ror2 (expressed in IESC, Goblet, Reg4+ secretory, and enteroendocrine cells). Similarly, Wnt2 (from CBFs1, CBFs2) would signal to canonical Wnt receptor Fzd3 (expressed in TA, Goblet, and enteroendocrine) (S3A Fig). In addition, we uncovered some interesting new potential crosstalk, such as between Fgf2 (from CBFs1 and CBFs2) and Cd44 (expressed in IESC and TA cells) and Fgfr2 (expressed in IESC, TA, Goblet, Reg4+ secretory, and enteroendocrine cells) (S3A Fig). Intriguingly, CBFs2 express the ligands Igf1, Efna2, Efna5, and Ptn whose receptors Igf1r (Igf1), Epha4 (Efna2, Efna5), and Ptprs (Ptn) are expressed on epithelial cells (S3A Fig). The relevance of this crosstalk needs to be explored.

Intriguingly, different Wnt signaling antagonists (Sfrp1, Sfrp2, Frzb, Sfrp4, and Dkk3) are expressed in distinct crypt-associated fibroblasts. This may serve to sharpen the gradient of canonical Wnt signaling activity (S2B Fig).

We also performed gene regulatory network analysis using single-cell regulatory network inference and clustering (SCENIC) [20]. This revealed cluster specific enrichment for transcription factor regulons. CTFs show an enrichment for the regulon activities of Lef1, Runx1, Nkx2-3, and Foxl1 (S2E Fig). The transcription factor Nkx2-3 had previously been found to control Bmp2/4 expression in the small intestine [21]. Lef1 regulon activity in CTFs may hint at a possible explanation for the presence of the recently discovered small intestinal Lgr5+ villus tip telocytes [22], given that Lgr5 is canonical Wnt targe gene [23], and Lef1 is both a canonical Wnt target gene and a Wnt/b-catenin transcription factor [24]. Intriguingly, this would also point to a difference in transcriptional regulation of Lgr5+ mesenchymal cells compared to Lgr5+ intestinal stem cells, which have been shown to mainly depend on TCF family member Tcf4 [25].

In conclusion, we identified two molecularly distinct colonic crypt-associated fibroblast populations, which are defined by their potential to either support the maintenance of epithelial stem cells or to induce the differentiation of the intestinal epithelium.

Spatial localization of crypt-associated fibroblasts

Finally, we sought to identify the position of the molecularly defined crypt-associated fibroblast populations along the colonic crypt axis. We analyzed colonic tissue sections of Pdgfra-H2B-eGFP reporter mice [26]. These display differences in nuclear green fluorescent protein (GFP) intensity closely correlated with the Pdgfra transcript levels and perfectly recapitulate differences in Pdgfra protein expression in the murine colon, as exemplified by the co-localization of nuclei with high GFP levels and cells exhibiting high intensity Pdgfra antibody staining (Fig 3A). All cells with GFP positive nuclei show subepithelial localization and co-expression with the pan-fibroblast maker Vimentin (S4A Fig). Fluorescence intensity quantification of GFP positive nuclei revealed a clear association between the localization of fibroblasts and nuclear GFP intensity. CTFs displayed high nuclear GFP signals (mean + SD: 117.1 + 37.9), and CBFs displayed low nuclear GFP signals (mean + SD: 39.5 +14.7) (Fig 3B and 3C). To further investigate the morphology of Pdgfra-expressing cells in the colon, we examined colon from mice carrying the Pdgfra-CreERT2 driver [27] in combination with the cytoplasmic fluorescent reporter mouse line Ai14 (LSL-tdTomato) [28] (single tamoxifen injection, analysis 1 day post injection). As has been previously observed in telocytes of the small intestine [22], we find that Pdgfra-expressing cells have elongated processes and small telopode portrusions (S4B Fig). The morphology is revealed by the distribution of tdTomato.

To validate the gene expression patterns found in our scRNAseq (Fig 2), we isolated colonic mesenchymal GFP-high and GFP-low cells from the Pdgfra-H2B-eGFP mouse line (Fig 3D, S4C Fig). Quantitative real-time PCR confirmed higher expression of Wnt2, Wnt2b, Rspo3, and Grem1 in GFP-low cells compared to GFP-high cells, recapitulating the differences observed between CBFs and CTFs in our scRNAseq (Fig 3E). As expected, Wnt5a and Pdgfra expression was higher in the GFP-high cells (Fig 3E).

In order to further corroborate our findings, we performed an independent scRNAseq analysis of GFP positive colonic mesenchymal cells of the Pdgfra-H2B-eGFP mouse line. Graph-based clustering revealed three main clusters (Fig 3F). Based on the expression of Pdgfra and various niche factors (Wnt2/2b, Grem1, Rspo3, and Wnt5a), we designated cluster P3 as CTFs and cluster P1 and P2 as CBFs1 and CBFs2 (S4D and S4E Fig). SMCs (possibly including myofibroblasts) were not found in this dataset. Based on the top 2,000 differentially expressed genes in each cluster, CBFs1, CBFs2, and CTFs originating from the Pdgfra-H2B-eGFP scRNAseq analysis show very high similarity (Spearman correlation) to the three Pdgfra positive clusters of the same name in our initial scRNAseq experiment (Fig 3G).

Taken together, these data confirm that CTFs and CBFs correspond to Pdgfra high and low expressing cells, respectively and are differentially localized along the crypt axis.

Murine colonic crypt-associated fibroblast identities are conserved in human healthy colon

In order to see whether the molecular identity of murine CBFs and CTFs are evolutionarily conserved, we compared our findings to human colonic stromal cell populations. To do so, we took advantage of the recently published dataset (GSE114374), in which human colonic stroma has been analyzed in inflammatory disease progression versus healthy state at single-cell level [12]. We performed a bioinformatic reanalysis of Kinchen’s healthy colonic stromal dataset. We find a total of 8 clusters, which we annotated, based on published markers [12] as fibroblasts, plasma cells, glia, endothelial cells, SMCs, and pericytes (Fig 4A). We interrogated the expression of previously published murine niche marker genes within the fibroblast clusters (Fig 4B). A very similar picture emerges to that seen in mouse (Fig 2B), with the exception of CD34, which is expressed solely in endothelial cells in the human colon.

Fig 4. Murine CTFs and CBFs populations are conserved in healthy human colon.

Fig 4

(A) Reanalysis of the healthy colonic stromal dataset from GSE114374 reveals landscape similar to murine colon. (UMAP, single cells are colored according to cluster annotation). (B) Conserved niche markers determine analogous cell populations in human colonic mesenchyme (UMAP, single cells are colored according to transcript expression). (C) Relative expression of PDGFRA separates human mesenchymal cells into three PDGFRA+ populations: CTFs, CBFs 1, and CBFs 2. (Violin plot, raw data: S1E Data) (D) Relative expression of factors involved in WNT and BMP pathways. (Violin and dot plots, size, and color of the dot represent the percentage of cells which express the transcript and the average expression level within a cluster, respectively; raw data: S1F Data). (E) Schematic model of conserved colonic crypt-associated fibroblasts. PDGFRAhigh CTFs secrete BMP ligands and noncanonical WNT ligands, resulting in epithelial differentiation. PDGFRAlow CBFs secrete canonical WNT ligands, WNT potentiators, and BMP inhibitors to maintain stem cells (blue). BMP, bone morphogenetic protein; CBF, crypt-bottom fibroblast; CTF, crypt-top fibroblast; PDGFRA, platelet-derived growth factor receptor A; UMAP, Uniform Manifold Approximation and Projection.

Interestingly, reinforcing our observations in the murine colon, the strength of PDGFRA expression can be used to demarcate distinct crypt-associated fibroblast populations in the human colon as well (Fig 4C). Taken together with the expression pattern of components of the WNT and BMP signaling pathways (Fig 4D), we identify clusters HC1 and HC3 as PDGFRAlow CBFs1 and CBFs2, respectively, that express canonical WNT ligands (WNT2B), WNT signaling potentiators (RSPO3), and BMP inhibitors (GREM1, GREM2, and CHRD). In addition, using the R package matchSCore2 [29], we compared the murine mesenchymal populations with the human mesenchymal populations on the level of the entire transcriptome. We found high interspecies overlap between murine and human CBFs, murine and human CTFs, and murine and human SMCs (S5 Fig).

However, diverging from the expression patterns observed in the murine colon, the canonical WNT ligand WNT2B is expressed not only in CBFs, but also additionally in SMCs (Fig 4D). This finding is consistent with a recent observation that embryonic SMCs express WNT2B during human intestinal development [30]. Moreover, we identify cluster HC2 as PDGFRAhigh CTFs, expressing a broad spectrum of BMP ligands (e.g., BMP2), and noncanonical WNT ligands (e.g., WNT5A) (Fig 4D). Interestingly, just like in the murine colon, we also find expression of various canonical WNT signaling inhibitors (SFRP1, SFRP2, FRZB, and DKK3) in all the fibroblast clusters in the human colon; however, compared to mouse, the positions of DKK3 and FRZB expression seems to be reversed in human CBFs and CTFs (Fig 4D and S2B Fig).

Future studies of this highly specific spatial localization and molecular regulation might reveal deeper mechanistic insights into how canonical WNT ligands and antagonists interact to create a canonical WNT signaling gradient optimal for intestinal stem cell maintenance and proliferation.

Discussion

Understanding the cellular and molecular architecture of the colon is crucial to comprehend how it functions in homeostasis and to find suitable strategies to treat colonic diseases. Colorectal cancer and inflammatory bowel disease are important disorders that pose a great challenge to modern medicine due to their widespread and complex pathology. In recent years, it has been shown that crosstalk between fibroblasts and epithelial cells plays an important role in the initiation and progression of these diseases [31,32].

In this study, we provide a comprehensive picture of the murine colonic cellular diversity and investigate in detail the identity of mesenchymal niche cells. We produced a high-quality single-cell transcriptome atlas of matched colonic epithelium and mesenchyme, creating a powerful resource to study cellular identities and pathway regulation during adult tissue homeostasis. We propose a novel classification of murine and human crypt-associated fibroblasts, based on their position relative to the crypt axis and their molecular identity (Model Fig 4E). Pdgfrahigh CTFs are located at the top of the crypt and secrete Bmp ligands (Bmp2/3/4/5/7) and noncanonical Wnt ligands (Wnt5a), thereby inducing differentiation in the nearby epithelial cells. Pdgfralow CBFs are located in close proximity to the intestinal stem cells at the bottom of the crypt. They secrete factors integral to stem cell maintenance, such as canonical Wnt ligands (Wnt2 and Wnt2b), Wnt signaling potentiators (Rspo3), and Bmp inhibitors (Grem1). Wnt2b has previously been shown to support the growth of intestinal organoids [33]. Expression of Pdgfrα has recently been described to be a useful marker for pericryptal stromal cells that act as source for Wnts and Rspo3 in the murine intestinal system [4]. Our work shows that this marker demarcates a second, additional signaling hub at the crypt top.

CTFs share characteristics with previously described intestinal telocytes, such as expression of Sox6 and F3 [12], as well as high expression of Foxl1 likely responsible for the high Foxl1 regulon activity described above [7,17]. The high expression of Wnt5a in CTFs is intriguing. Taken together with the expression of Bmp ligands (e.g., Bmp2 and Bmp4) and marker gene F3, the data suggest that the colonic CTFs are likely analogous to the villus tip telocytes observed in the small intestine [22]. Wnt5a has been show to inhibit canonical Wnt signaling by down-regulating transcription of Wnt target genes [34,35], which is consistent with the proposed role of CTFs in orchestrating epithelial differentiation. Upon intestinal injury, Wnt5a is required for the proper subdivision of wound channels and thereby the formation of new crypts [36]. During embryogenesis, Wnt5a is involved in the clustering of the mesenchymal core below prospective epithelial invaginations—an integral process for crypt formation in the developing gastrointestinal system [37]. The role of Wnt5a in homeostasis of this tissue remains to be explored.

CBFs co-express most previously discussed stem cell niche-cell markers, such as Gli1 [6], Pdgfra [4], Cd90 [8], and Cd34 [5]. Importantly though, none of these markers is truly definitive. Gli1 and Pdgfra are expressed in all intestinal crypt-associated fibroblasts; Cd90 and Cd34 are additionally expressed in SMCs and endothelial cells, respectively. Ultimately, it is the combination of these markers that delineate CBFs and thereby the stem cell niche.

Together, CBFs and CTFs generate the antagonistic gradients of canonical Wnt signaling and Bmp signaling, which dictate the zones of epithelial proliferation and differentiation [3]. In the small intestine, the Bmp signaling gradient has recently been described to be formed via ligand secretion by villus telocytes and antagonist secretion by Cd81+ trophocytes [9]. Our observations about CTFs and CBFs allow to draw a similar picture in the colon, where the two fibroblast populations, which are distinguishable by their level of Pdgfra expression, produce either Bmp signals (CTFs) or Bmp inhibitors (CBFs). There are striking differences between the small intestine and the colon, both in morphology and niche signals. The epithelium of the small intestine consists of crypts and villi, whereas only crypts are found in the colonic epithelium. Canonical Wnt ligands, which are integral to intestinal epithelial stem cell maintenance, are redundantly secreted by epithelial Paneth cells [38], as well as mesenchymal cells [47,17] in the small intestine. In the colon, there is no epithelial Wnt source. Accordingly, the requirement for the mesenchymal niche (e.g., canonical Wnt signals) is not necessarily the same in colon and small intestine. However, combined, the data produced by us and McCarthy and colleagues [9] show a strong conservation in intestinal fibroblast identity and corroborates the validity of using Pdgfra expression levels as a marker to distinguish stem cell–supporting fibroblasts from fibroblasts that induce epithelial differentiation.

The difference in Pdgfra expression level as a marker for fibroblast populations has been described in the lung, where it serves to discriminate between lipofibroblasts and myofibroblasts [3941]. We note a correlation between high Pdgfra expression and Acta2 expression in CTFs (Fig 2D), pointing toward a possible myofibroblast identity of these cells. However, in lung fibroblasts, there are conflicting findings—both correlation [39] and anticorrelation [40]—have been reported. Ultimately, it remains to be elucidated, both in the lung and the gastrointestinal system, whether the different Pdgfra expression levels control the identity and ultimately function of the two fibroblast populations.

In conclusion, we propose here a novel classification of intestinal crypt-associated fibroblasts: CBFs and CTFs. It will be imperative to investigate the roles of these two fibroblast populations in the context of tumor initiation, progression, and metastasis.

Materials and methods

Ethics statement

All mouse procedures were performed in accordance with Swiss Guidelines and approved by the Cantonal Veterinary Office Zürich, Switzerland (ZH156/2015 and ZH169/2016).

Mice

C57BL/6 wild-type mice were purchased from Charles River, Germany (Strain code: 027). PdgfraH2BeGFP [26], Pdgfra-CreERT2 [27], and Ai14 [28] mice were purchased from Jackson Laboratories, United States of America (Stock numbers: 007669, 032770, and 007914). Cells were isolated from female mice at age 8 to 12 weeks.

Epithelial and mesenchymal cell isolation and cell sorting

Colonic epithelial and mesenchymal cells were isolated inspired by previous publications [42,43] and modified as described below. Colonic tissue was harvested, minced into small pieces (2 mm), and subsequently washed with PBS. Tissue pieces were then incubated in Gentle Cell Dissociation Reagent (STEMCELL Technologies, Germany) for 30 minutes at room temperature to detach the epithelium. The epithelial fraction was then filtered through a Falcon 70-μm cell strainer (Corning, Switzerland), washed with plain ADMEM/F12 and incubated for 5 minutes at 37°C in prewarmed TrypLE express (Gibco, Thermofisher, Switzerland), followed by single-cell dissociation using the m_intestine program on the gentleMACS Octo Dissociator (Miltenyi Biotec, Switzerland). The epithelial single-cell suspension was then filtered through a Falcon 40-μm cell strainer (Corning) and stored on ice in ADMEM/F12 (supplemented with 10% FBS). After the detachment of the epithelium, the remaining tissue pieces were digested for 1 hour at 37°C under 110 revolutions per minute (rpm) shaking conditions in DMEM supplemented with 2 mg/mL collagenase D (Roche) and 0.4 mg/mL Dispase (Gibco). The mesenchymal fraction was then filtered through a Falcon 70-μm cell strainer (Corning), washed with plain ADMEM/F12, and subsequently filtered through a Falcon 40-μm cell strainer (Corning). Both epithelial and mesenchymal cells were stained for 30 minutes on ice with anti-CD45-PE (1:500, eBioscience/Thermofisher, Switzerland) and anti-CD326(EpCAM)-FITC (1:500, eBioscience/Thermofisher, Switzerland) in ADMEM/F12 (supplemented with 10% FBS). Prior to cell sorting, all cells were stained for 5 minutes on ice with Zombie Violet Fixable Viability Kit in PBS (1:1000, Biolegend, Thermofisher, Switzerland). In the case of mesenchymal cell isolation from PdgfraH2BeGFP, mice only staining with Zombie Violet Fixable Viability Kit was performed. Cells were detected and sorted at the Cytometry Facility at the University of Zürich using a FACSAria III cell sorter (gates visible in corresponding figures) (BD Biosciences, Switzerland).

Single-cell RNA sequencing

Colonic epithelial and mesenchymal cells (Fig 1) were isolated from three female C57BL/6 mice as described above and mixed at a ratio of 1:1. Using the Single Cell 3’ V3 assay, 16,000 cells were loaded on a Chromium Controller (10x Genomics, USA). Colonic mesenchymal Pdgfra-positive cells (Fig 3) were isolated as described above from three female PdgfraH2BeGFP mice. Using the Single Cell 3’ V2 assay, 16,000 cells were loaded on a Chromium Controller (10x Genomics). In both cases reverse transcription, cDNA synthesis/amplification and library preparation were carried out in accordance with the manufacturer’s recommendations by the Functional Genomics Center Zürich (FGCZ). scRNA libraries were sequenced on a NovaSeq 6000 instrument (Illumina, Switzerland).

Tissue isolation, cryosectioning, and immunohistochemistry

Colonic tissue was harvested from female PdgfraH2BeGFP mice, fixed for 1 hour at room temperature in 4% paraformaldehyde in PBS (ChemCruz/Santa Cruz Biotechnology, USA), and incubated O/N in 30% sucrose in PBS at 4°C. Tissue was then kept in a 1:1 mix of 30% sucrose and optimal cutting temperature (OCT) (TissueTek/Biosystems Switzerland) for 30 minutes at 4°C, before embedding in OCT and being cooled to −80°C. OCT-embedded tissue was cryosectioned using a Microm HM560 Cryostat (Thermo Fisher Scientific, Switzerland) at 5 μm, dried for 2 hours at room temperature before either being directly used for immunohistochemistry, or stored at −80°C. Standard immunohistochemical protocols were performed with the following primary antibodies (1:100 dilution): mouse-anti-Acta2 (Sigma, Germany), goat-anti-Pdgfra (R&D Systems, USA), chicken-anti-Vimentin (Millipore, USA), and rabbit-anti-EpCAM (Abcam, UK). Secondary antibodies (1:400 dilution) were anti-rabbit, anti-mouse, anti-goat antibodies conjugated with Alexa Dyes (A555, A598, or A647) (Thermo Fisher Scientific, Switzerland). Sections were counterstained with DAPI, mounted with FluorSave reagent (Sigma), imaged on a Leica SP8 laser scanning confocal microscope (Leica, Switzerland), and subsequently processed using ImageJ (FIJI).

In situ RNA hybridization

mRNAs were localized in specific cells using the RNAscope method (Advanced Cell Diagnostics, Germany) on colonic tissue sections according to manufacturer’s instructions (RNAscope Fluorescent Multiplex Assay). Probe sets for Wnt5a was designed by Advanced Cell Diagnostics. Images were obtained on a Leica SP8 laser scanning confocal microscope.

RNA isolation, cDNA synthesis, and quantitative real-time PCR

Total RNA from Pdgfra-high and Pdgfra-low cells (Fig 4) was isolated using the mirVana miRNA Isolation Kit (Thermo Fisher Scientific) according to the manufacturer’s instructions. cDNA was synthesized using the RNA to cDNA EcoDry synthesis kit (TaKaRa/Thermo Fisher Scientific, Switzerland). Quantitative real-time PCR reactions were performed with technical triplicates using the SYBR Green Kit (Applied Biosystems/Thermo Fisher Scientific, Switzerland) and monitored by the QuantStudio3 system (Applied Biosystems). Sequences of the used primers are: Hprt: AAG CTT GCT GGT GAA AAG GA, TTG CGC TCA TCT TAG GCT TT; Pdgfra: TCC TTC TAC CAC CTC AGC GAG, CCG GAT GGT CAC TCT TTA GGA AG; Wnt2: CTG AGT GGA CTG CAG AGT GC, ACA ACG CCA GCT GAA GAG AT; Wnt2b: CAC CCG GAC TGA TCT TGT CT, TGT TTC TGC ACT CCT TGC AC; Wnt5a: CAG GGT GAT GCA AAT AGG CAG, AGC CAT AGT CGA TGT TGT CTC C; Rspo3: ACT ACA GCA TCC TTC AGC C, TTT TCG TTT TCT CTC TCT TCC C; and Grem1: ACC CAG AGT ACC GTG GT, GTG TAT GCG GTG CGA TTC A.

Computational analysis for scRNA-seq

Preprocessing

The sequencing libraries were de-multiplexed, aligned to the mouse transcriptome (mm10), and unique molecular identifiers (UMI) were counted using Cell Ranger (10x Genomics) version 3.0.1 by the FGCZ. Further data analysis was performed using the Seurat package version 3.1 [44] in R version 3.6.2. For the in-depth analysis of colonic cell populations (Fig 1C), cells with counts in more than 200 genes and genes that were detected in more than 5 cells were retained, resulting in 10,427 cells and 17,956 genes. Following a second round of quality control, only cells with counts in 500 to 7,500 genes and <25% mitochondrial genes were retained, resulting in a final dataset consisting of 7,395 cells. Pdgfra+ cells (Fig 3F) with counts in more than 200 genes and genes that were detected in more than 5 cells were retained, resulting in 4,500 cells and 16,055 genes. Following a second round of quality control, only cells with counts in 500 to 4,000 genes and <10% mitochondrial genes were retained, resulting in a final dataset consisting of 4,409 cells. For the reanalysis of the human colonic mesenchymal cell dataset [12] (Fig 4A), cells with counts in more than 200 genes and genes that were detected in more than 5 cells were retained, resulting in 4,369 cells and 17,652 genes. Following a second round of quality control, only cells with counts in 500 to 4,000 genes were retained, resulting in a final dataset consisting of 4,302 cells.

Dimensionality reduction and clustering

For all three datasets, normalization, scaling, and variable gene selection was performed using the “SCTransform” function in Seurat [45] with standard settings. Following principle component analysis, dimensionality reduction using Uniform Manifold Approximation and Projection (UMAP) algorithm [46] was performed using 30 principal components (PCs). Clusters were then identified using the “FindNeighbors” and “FindClusters” functions in Seurat with resolution parameters of 0.45 (Fig 1C) and 0.3 (Figs 3F and 4A). Clusters were then annotated based on known epithelial and stromal marker genes in addition to the “FindMarkers” function in Seurat. Marker heatmaps (S1B Fig, Fig 2G) were generated using the genesorteR package version 0.4.2 [47] with a quant setting of 0.97 (S1B Fig) and 0.95 (Fig 2G). Density plots (S3B Fig) were generated using the Nebulosa package version 0.99.94 [48], with standard settings.

Gene Ontology analysis

GO networks were generated using ClueGO [49] version 2.5.5 via Cytoscape version 3.7.2 [50]. The network clustering contained data from GO_BiologicalProcess-EBI-UniProtGOA, REACTOME_ Reactions, REACTOME_Pathways, KEGG_Pathways, WikiPathways, and BioCyc. Clusters contained at least three nodes, and network specificity was adjusted based on the number of genes, which originated from high expressing genes in each cluster analyzed via the “FindMarkers” function in Seurat.

Gene regulatory network analysis

Transcription factor regulon activity in specific stromal clusters (S2E Fig) was analyzed using SCENIC version 1.1.2.2 [20], with default settings according to the “running SCENIC” vignette.

Dataset similarity

Dataset similarity (S5A Fig) was calculated using matchSCore2 version 0.1.0 [29], with default settings.

Ligand–receptor interactions

Ligand–receptor interactions (S3A Fig) were generated using the python package CellphoneDB version 2.1.4 [19], with default parameters.

Quantification of GFP-positive nuclei

Images acquired on the Leica SP8 confocal microscope were imported into FIJI [51] in the form of Z-stacks and processed by Z-projection (maximum projection). In order to quantify the GFP fluorescence, intensity of individual GFP positive nuclei a threshold (Huang algorithm, auto settings) was applied to the GFP channel. The result was further binarized and improved by filling holes and applying a watershed filter. The nuclei were segmented using the analyze particle function (settings: 8-Infinity, circularity: 0–1). The segmentation was overlaid on the DAPI channel and all nuclei of low quality (e.g., partially sectioned/dim nuclei that were not fully captured in the Z-stack) or of inconclusive position in regards to their crypt-associated position (top, bottom) were excluded. Average fluorescence intensity of the remaining nuclei in the GFP channel was measured and analyzed using Prism 8 (GraphPad, USA).

Quantitative real-time PCR

For quantitative reverse transcription PCR (RT-qPCR), samples were measured in triplicate and average cycle threshold values were quantified relative to Hprt using the ΔΔCT method.

Supporting information

S1 Fig. Interrogation of the colonic epithelium reveals a variety of known and unknown growth factors.

(A) Cell numbers of the particular clusters indicated in Fig 1C. (B) Heatmap of genes that are differentially expressed among the epithelial clusters (0.97 quantile), reveals heterogeneity between and similarity within the major epithelial lineages (stem-/transit-amplifying-, secretory-, absorptive-, enteroendocrine cells). (C) Relative expression of epithelial signaling pathway components. (Dot plot, size, and color of the dot represent the percentage of cells which express the transcript and the average expression level within a cluster, respectively). (D) GO enrichment terms for Enterocyte 1. GO, Gene Ontology.

(TIF)

S2 Fig. Growth factors produced by colonic mesenchymal cells.

(A) GO enrichment terms for SMC. (B) Relative expression of factors involved in WNT, BMP, and RTK/MAPK pathways. (Dot plot, size, and color of the dot represents the percentage of cells which express the transcript and the average expression level within a cluster, respectively). (C) GO enrichment terms for CBFs 1. (D) GO enrichment terms for CBFs 2. (E) Heatmap showing the specific enrichment for transcription factor regulon activity in specific stromal clusters (scaled regulon activity, SCENIC). Bmp, bone morphogenetic protein; CBF, crypt-bottom fibroblast; GO, Gene Ontology; MAPK, mitogen-activated protein kinase; RTK, receptor tyrosine kinase; SCENIC, single-cell regulatory network inference and clustering; SMC, smooth muscle cell.

(TIF)

S3 Fig. Interactome of colonic mesenchymal cells.

(A) Putative ligand–receptor interactions between CBFs1, CBFs2, CTFs, and colonic epithelial subpopulations. Size of the dots represents the significance of the interaction, and color shows the expression of the ligand and receptor in the interacting cell types (CellphoneDB). (B) Density of Wnt2, Wnt2b, Cd81, Grem1, and Rspo3 expressing cells. (UMAP, color indicates the density of cells expressing transcript). CBF, crypt-bottom fibroblast; CTF, crypt-top fibroblast; UMAP, Uniform Manifold Approximation and Projection.

(TIF)

S4 Fig. Fibroblast identity of CTFs and CBFs.

(A, B) Cryosections of Pdgfra-H2B-eGFP mice (A) and Pdgfra-CreERT2; LSL-tdTomato mice (B). (A) Vimentin expression (red) in Pdgfra+ cells (green) on representative Pdgfra-H2B-eGFP colonic tissue sections confirms their fibroblast identity. (Scale bar = 40 μm) (1,2) Insets of crypt top and crypt bottom, respectively (Scale bar = 5 μm). (B) Pdgfra-CreERT2; LSL-tdTomato lineage tracing (single tamoxifen injection, 1 d.p.i.) reveals morphology of Pdgfra-expressing cells, tdTomato (white) (Scale bar = 10 μm) (C) Flow cytometry analysis for GFP of a mesenchymal single-cell suspension isolated from Pdgfra-H2B-eGFP mice. (Raw data: S5 Data) (D, E) Relative expression of Pdgfra (D) and colonic niche factors (E) in Pdgfra+ colonic mesenchymal cells. (UMAP, single cells are colored according to transcript expression). CBF, crypt-bottom fibroblast; CTF, crypt-top fibroblast; d.p.i., days post injection; Pdgfra, platelet-derived growth factor receptor A; UMAP, Uniform Manifold Approximation and Projection.

(TIF)

S5 Fig. Interspecies conservation of colonic mesenchymal subpopulations.

(A) Heatmap showing the similarity (Jaccard index) of murine and human colonic mesenchymal subpopulations (matchSCore2).

(TIF)

S1 Data. This file contains the raw data for the indicated figures.

(A) Transcript expression of Pdgfra for Fig 2C. (B) Transcript expression of Vim, Col1a1, Acta2, Myh11, Wnt2, Wnt2b, Rspo3, Grem1, Wnt5a, Bmp3, and Bmp7 for Fig 2D. (C) Numeric values and statistical analysis of the PdgfraEGFP fluorescence intensity quantification in Fig 3C. (D) Raw data and fold change calculation of the qPCR data shown in Fig 3E. (E) Transcript expression of PDGFRA for Fig 4C. (F) Transcript expression of WNT2B, WNT5A, RSPO3, BMP2, and GREM1 for Fig 4D. Bmp, bone morphogenetic protein; Pdgfra, platelet-derived growth factor receptor A; qPCR, quantitative polymerase chain reaction.

(XLSX)

S2 Data. FCS file containing the raw data of the FACS sorting of the epithelial cell isolation depicted in Fig 1B.

FACS, fluorescence-activated cell sorting; FCS, flow cytometry standard.

(FCS)

S3 Data. FCS file containing the raw data of the FACS sorting of the mesenchymal cell isolation depicted in Fig 1B.

FACS, fluorescence-activated cell sorting; FCS, flow cytometry standard.

(FCS)

S4 Data. FCS file containing the raw data of the FACS sorting of two populations (low and high) of PdgfraEGFP positive cells depicted in Fig 3D.

FACS, fluorescence-activated cell sorting; FCS, flow cytometry standard.

(FCS)

S5 Data. FCS file containing the raw data of the FACS sorting for PdgfraEGFP positive cells depicted in S4C Fig.

FACS, fluorescence-activated cell sorting; FCS, flow cytometry standard.

(FCS)

Acknowledgments

We are grateful to all members of the Basler lab and in particular to J. Reichmuth and J. Schopp for valuable comments and to members of the Moor lab and Schwank lab for advice. For technical help, we thank E. Escher, the Functional Genomics Center Zurich, and the Cytometry Facility of University of Zurich.

Abbreviations

Bmp

bone morphogenetic protein

CBF

crypt-bottom fibroblast

CTF

crypt-top fibroblast

EGF

epidermal growth factor

ERK

extracellular signal-regulated kinase

FACS

fluorescence-activated cell sorting

FGCZ

Functional Genomics Center Zürich

GFP

green fluorescent protein

GO

Gene Ontology

IESC

intestinal epithelial stem cell

OCT

optimal cutting temperature

PC

principal component

Pdgfra

platelet-derived growth factor receptor A

rpm

revolutions per minute

RT-qPCR

quantitative reverse transcription PCR

SCENIC

single-cell regulatory network inference and clustering

scRNAseq

single-cell RNA sequencing

SMC

smooth muscle cell

TA

transit-amplifying cell

UMI

unique molecular identifier

Data Availability

Single-cell RNA sequencing data generated in this study are deposited in GEO with the accession number GSE151257. All data needed to reproduce the figures in this publication can be found in the supporting information. The FACS sorting plots in Fig 1B, Fig 3D and S4C Fig are based on the .fcs data files in n S2 Data, S3 Data, S4 Data and S5 Data respectively. Transcript expression data for the violin plots in Fig 2C and 2D and Fig 4C and 4D can be found in S1A, S1B, S1E and S1F Data respectively. Fluorescence intensity measurements in Fig 3C and statistical analysis can be found in S1C Data. Raw data for the qPCR data in Fig 3E can be found in n S1D Data.

Funding Statement

This work was supported by the Swiss National Science Foundation (http://www.snf.ch/de/Seiten/default.aspx), the University of Zurich Research Priority Program (URPP) “Translational Cancer Research” (https://www.cancer.uzh.ch/en.html) and the Kanton of Zürich (https://www.zh.ch/de.html). MDB is supported by the University of Zürich Forschungskredit Candoc grant Nr. FK-19-074 (https://www.research.uzh.ch/en/funding/phd/fkcandoc.html). TV is supported by Czech Science Foundation grant 18-21466S (https://gacr.cz/en/) and is a fellow of the URPP Translational Cancer Research (https://www.cancer.uzh.ch/en.html). HF is a fellow of the Cancer Research Center Zurich (CRC) (http://www.cancercenter.usz.ch/forschung/cancer-research-center/Seiten/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Powell DW, Pinchuk IV, Saada JI, Chen X, Mifflin RC. Mesenchymal Cells of the Intestinal Lamina Propria. Annu Rev Physiol. 2011;73:213–37. 10.1146/annurev.physiol.70.113006.100646 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol. 2014;15:19–33. 10.1038/nrm3721 [DOI] [PubMed] [Google Scholar]
  • 3.Gehart H, Clevers H. Tales from the crypt: new insights into intestinal stem cells. Nat Rev Gastroenterol Hepatol. 2019;16:19–34. 10.1038/s41575-018-0081-y [DOI] [PubMed] [Google Scholar]
  • 4.Greicius G, Kabiri Z, Sigmundsson K, Liang C, Bunte R, Singh MK, et al. PDGFRα+ pericryptal stromal cells are the critical source of Wnts and RSPO3 for murine intestinal stem cells in vivo. PNAS. 2018;115:E3173–81. 10.1073/pnas.1713510115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Stzepourginski I, Nigro G, Jacob J-M, Dulauroy S, Sansonetti PJ, Eberl G, et al. CD34+ mesenchymal cells are a major component of the intestinal stem cells niche at homeostasis and after injury. PNAS. 2017;114:E506–13. 10.1073/pnas.1620059114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Degirmenci B, Valenta T, Dimitrieva S, Hausmann G, Basler K. GLI1-expressing mesenchymal cells form the essential Wnt-secreting niche for colon stem cells. Nature. 2018;1 10.1038/s41586-018-0190-3 [DOI] [PubMed] [Google Scholar]
  • 7.Shoshkes-Carmel M, Wang YJ, Wangensteen KJ, Tóth B, Kondo A, Massassa EE, et al. Subepithelial telocytes are an important source of Wnts that supports intestinal crypts. Nature. 2018;557:242–6. 10.1038/s41586-018-0084-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Karpus ON, Westendorp BF, Vermeulen JLM, Meisner S, Koster J, Muncan V, et al. Colonic CD90+ Crypt Fibroblasts Secrete Semaphorins to Support Epithelial Growth. Cell Rep. 2019;26:3698–3708.e5. 10.1016/j.celrep.2019.02.101 [DOI] [PubMed] [Google Scholar]
  • 9.McCarthy N, Manieri E, Storm EE, Saadatpour A, Luoma AM, Kapoor VN, et al. Distinct Mesenchymal Cell Populations Generate the Essential Intestinal BMP Signaling Gradient. Cell Stem Cell. 2020;0 10.1016/j.stem.2020.01.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ayyaz A, Kumar S, Sangiorgi B, Ghoshal B, Gosio J, Ouladan S, et al. Single-cell transcriptomes of the regenerating intestine reveal a revival stem cell. Nature. 2019;1 10.1038/s41586-019-1154-y [DOI] [PubMed] [Google Scholar]
  • 11.Parikh K, Antanaviciute A, Fawkner-Corbett D, Jagielowicz M, Aulicino A, Lagerholm C, et al. Colonic epithelial cell diversity in health and inflammatory bowel disease. Nature. 2019;567:49 10.1038/s41586-019-0992-y [DOI] [PubMed] [Google Scholar]
  • 12.Kinchen J, Chen HH, Parikh K, Antanaviciute A, Jagielowicz M, Fawkner-Corbett D, et al. Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease. Cell. 2018;0 10.1016/j.cell.2018.08.067 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Haber AL, Biton M, Rogel N, Herbst RH, Shekhar K, Smillie C, et al. A single-cell survey of the small intestinal epithelium. Nature. 2017;551:333–9. 10.1038/nature24489 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sasaki N, Sachs N, Wiebrands K, Ellenbroek SIJ, Fumagalli A, Lyubimova A, et al. Reg4+ deep crypt secretory cells function as epithelial niche for Lgr5+ stem cells in colon. PNAS. 2016;113:E5399–407. 10.1073/pnas.1607327113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pellegrinet L, Rodilla V, Liu Z, Chen S, Koch U, Espinosa L, et al. Dll1- and Dll4-Mediated Notch Signaling Are Required for Homeostasis of Intestinal Stem Cells. Gastroenterology. 2011;140:1230–1240.e7. 10.1053/j.gastro.2011.01.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kosinski C, Stange DE, Xu C, Chan AS, Ho C, Yuen ST, et al. Indian Hedgehog Regulates Intestinal Stem Cell Fate Through Epithelial−Mesenchymal Interactions During Development. Gastroenterology. 2010;139:893–903. 10.1053/j.gastro.2010.06.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Aoki R, Shoshkes-Carmel M, Gao N, Shin S, May CL, Golson ML, et al. Foxl1-Expressing Mesenchymal Cells Constitute the Intestinal Stem Cell Niche. Cell Mol Gastroenterol Hepatol. 2016;2:175–88. 10.1016/j.jcmgh.2015.12.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Yuh D-Y, Maekawa T, Li X, Kajikawa T, Bdeir K, Chavakis T, et al. The secreted protein DEL-1 activates a β3 integrin–FAK–ERK1/2–RUNX2 pathway and promotes osteogenic differentiation and bone regeneration. J Biol Chem. 2020;295:7261–73. 10.1074/jbc.RA120.013024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Efremova M, Vento-Tormo M, Teichmann SA, Vento-Tormo R. CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes. Nat Protoc. 2020;15:1484–506. 10.1038/s41596-020-0292-x [DOI] [PubMed] [Google Scholar]
  • 20.Aibar S, González-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14:1083–6. 10.1038/nmeth.4463 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Pabst O, Zweigerdt R, Arnold HH. Targeted disruption of the homeobox transcription factor Nkx2-3 in mice results in postnatal lethality and abnormal development of small intestine and spleen. Development. 1999;126:2215–25. [DOI] [PubMed] [Google Scholar]
  • 22.Bahar Halpern K, Massalha H, Zwick RK, Moor AE, Castillo-Azofeifa D, Rozenberg M, et al. Lgr5+ telocytes are a signaling source at the intestinal villus tip. Nat Commun. 2020;11:1–12. 10.1038/s41467-020-15714-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–7. 10.1038/nature06196 [DOI] [PubMed] [Google Scholar]
  • 24.Hoppler S, Kavanagh CL. Wnt signalling: variety at the core. J Cell Sci. 2007;120:385–93. 10.1242/jcs.03363 [DOI] [PubMed] [Google Scholar]
  • 25.van Es JH, Haegebarth A, Kujala P, Itzkovitz S, Koo B-K, Boj SF, et al. A Critical Role for the Wnt Effector Tcf4 in Adult Intestinal Homeostatic Self-Renewal. Mol Cell Biol. 2012;32:1918–27. 10.1128/MCB.06288-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hamilton TG, Klinghoffer RA, Corrin PD, Soriano P. Evolutionary Divergence of Platelet-Derived Growth Factor Alpha Receptor Signaling Mechanisms. Mol Cell Biol. 2003;23:4013–25. 10.1128/mcb.23.11.4013-4025.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Chung M-I, Bujnis M, Barkauskas CE, Kobayashi Y, Hogan BLM. Niche-mediated BMP/SMAD signaling regulates lung alveolar stem cell proliferation and differentiation. Development. 2018;145:dev163014 10.1242/dev.163014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010;13:133–40. 10.1038/nn.2467 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mereu E, Lafzi A, Moutinho C, Ziegenhain C, McCarthy DJ, Álvarez-Varela A, et al. Benchmarking single-cell RNA-sequencing protocols for cell atlas projects. Nat Biotechnol. 2020;38:747–55. 10.1038/s41587-020-0469-4 [DOI] [PubMed] [Google Scholar]
  • 30.Czerwinski M, Holloway EM, Tsai Y-H, Wu A, Yu Q, Wu JH, et al. In vitro and in vivo development of the human intestine at single cell resolution. bioRxiv. 2020; 2020.01.31.928788. 10.1101/2020.01.31.928788 [DOI] [Google Scholar]
  • 31.Tommelein J, Verset L, Boterberg T, Demetter P, Bracke M, De Wever O. Cancer-Associated Fibroblasts Connect Metastasis-Promoting Communication in Colorectal Cancer. Front Oncol. 2015;5 10.3389/fonc.2015.00063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Roulis M, Flavell RA. Fibroblasts and myofibroblasts of the intestinal lamina propria in physiology and disease. Differentiation. 2016;92:116–31. 10.1016/j.diff.2016.05.002 [DOI] [PubMed] [Google Scholar]
  • 33.Farin HF, Van Es JH, Clevers H. Redundant Sources of Wnt Regulate Intestinal Stem Cells and Promote Formation of Paneth Cells. Gastroenterology. 2012;143:1518–1529.e7. 10.1053/j.gastro.2012.08.031 [DOI] [PubMed] [Google Scholar]
  • 34.Mikels AJ, Nusse R. Purified Wnt5a Protein Activates or Inhibits β-Catenin–TCF Signaling Depending on Receptor Context. PLoS Biol. 2006;4:e115 10.1371/journal.pbio.0040115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Wu X, van Dijk EM, Ng-Blichfeldt J-P, Bos IST, Ciminieri C, Königshoff M, et al. Mesenchymal WNT-5A/5B Signaling Represses Lung Alveolar Epithelial Progenitors. Cell. 2019;8:1147 10.3390/cells8101147 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Miyoshi H, Ajima R, Luo CT, Yamaguchi TP, Stappenbeck TS. Wnt5a Potentiates TGF-β Signaling to Promote Colonic Crypt Regeneration After Tissue Injury. Science. 2012;338:108–13. 10.1126/science.1223821 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Rao-Bhatia A, Zhu M, Yin W-C, Coquenlorge S, Zhang X, Woo J, et al. Hedgehog-Activated Fat4 and PCP Pathways Mediate Mesenchymal Cell Clustering and Villus Formation in Gut Development. Dev Cell. 2020;52:647–658.e6. 10.1016/j.devcel.2020.02.003 [DOI] [PubMed] [Google Scholar]
  • 38.Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, van den Born M, et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 2011;469:415–8. 10.1038/nature09637 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.McGowan SE, Grossmann RE, Kimani PW, Holmes AJ. Platelet-Derived Growth Factor Receptor-Alpha-Expressing Cells Localize to the Alveolar Entry Ring and Have Characteristics of Myofibroblasts During Pulmonary Alveolar Septal Formation. Anat Rec. 2008;291:1649–61. 10.1002/ar.20764 [DOI] [PubMed] [Google Scholar]
  • 40.Chen L, Acciani T, Le Cras T, Lutzko C, Perl A-KT. Dynamic Regulation of Platelet-Derived Growth Factor Receptor α Expression in Alveolar Fibroblasts during Realveolarization. Am J Respir Cell Mol Biol. 2012;47:517–27. 10.1165/rcmb.2012-0030OC [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Gouveia L, Betsholtz C, Andrae J. Expression analysis of platelet-derived growth factor receptor alpha and its ligands in the developing mouse lung. Physiol Rep. 2017;5 10.14814/phy2.13092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Sato T, Clevers H. Primary Mouse Small Intestinal Epithelial Cell Cultures In: Randell SH, Fulcher ML, editors. Epithelial Cell Culture Protocols: Second Edition Totowa, NJ: Humana Press; 2013. pp. 319–328. 10.1007/978-1-62703-125-7_19 [DOI] [PubMed] [Google Scholar]
  • 43.Koliaraki V, Kollias G. Isolation of Intestinal Mesenchymal Cells from Adult Mice. BIO-PROTOCOL. 2016;6 10.21769/BioProtoc.1940 [DOI] [Google Scholar]
  • 44.Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36:411–20. 10.1038/nbt.4096 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Hafemeister C, Satija R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 2019;20:296 10.1186/s13059-019-1874-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.McInnes L, Healy J, Melville J. UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction. arXiv:180203426 [cs, stat]. 2018. [cited 11 May 2020]. Available: http://arxiv.org/abs/1802.03426. [Google Scholar]
  • 47.Mahmoud M Ibrahim, Rafael Kramann. genesorteR: Feature Ranking in Clustered Single Cell Data | bioRxiv. [cited 11 May 2020]. Available: https://www.biorxiv.org/content/10.1101/676379v2.
  • 48.Alquicira-Hernandez J, Powell JE. Nebulosa recovers single cell gene expression signals by kernel density estimation. bioRxiv. 2020; 2020.09.29.315879. 10.1101/2020.09.29.315879 [DOI] [PubMed] [Google Scholar]
  • 49.Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25:1091–3. 10.1093/bioinformatics/btp101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 2003;13:2498–504. 10.1101/gr.1239303 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676–82. 10.1038/nmeth.2019 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Ines Alvarez-Garcia

28 Jul 2020

Dear Dr Valenta,

Thank you for submitting your manuscript entitled "Distinct populations of crypt-associated fibroblasts act as signaling hubs to control colon homeostasis" for consideration as a Short Report by PLOS Biology. Thank you also for your patience as we completed our editorial process, and please accept my apologies for the delay in providing you with our decision.

Your manuscript has now been evaluated by the PLOS Biology editorial staff as well as by an academic editor with relevant expertise and I am writing to let you know that we would like to send your submission out for external peer review.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Please re-submit your manuscript within two working days, i.e. by Jul 30 2020 11:59PM.

Login to Editorial Manager here: https://www.editorialmanager.com/pbiology

During resubmission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF when you re-submit.

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. Once your manuscript has passed all checks it will be sent out for review.

Given the disruptions resulting from the ongoing COVID-19 pandemic, please expect delays in the editorial process. We apologise in advance for any inconvenience caused and will do our best to minimize impact as far as possible.

Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission.

Kind regards,

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor

PLOS Biology

ialvarez-garcia@plos.org

Carlyle House, Carlyle Road

Cambridge, CB4 3DN

+44 1223–442810

Decision Letter 1

Ines Alvarez-Garcia

28 Sep 2020

Dear Tomas and Konrad,

Thank you very much for submitting your manuscript "Distinct populations of crypt-associated fibroblasts act as signaling hubs to control colon homeostasis" for consideration as a Short Report at PLOS Biology. Thank you also for your patience as we completed our editorial process, and please accept my apologies again for the delay in providing you with our decision. Your manuscript has been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and by three independent reviewers.

The reviews are attached below. You will see that the reviewers find your results interesting, high quality and a good resource for the field. Thus we are pleased to offer you the opportunity to address all the points raised by the reviewers in a revised version that we anticipate should not take you very long. We will then assess your revised manuscript and your response to the reviewers' comments and we may consult the reviewers again.

We expect to receive your revised manuscript within 1 month.

Please email us (plosbiology@plos.org) if you have any questions or concerns, or would like to request an extension. At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may end consideration of the manuscript at PLOS Biology.

**IMPORTANT - SUBMITTING YOUR REVISION**

Your revisions should address the specific points made by each reviewer. Please submit the following files along with your revised manuscript:

1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript.

*NOTE: In your point by point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually.

You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response.

2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Related" file type.

*Resubmission Checklist*

When you are ready to resubmit your revised manuscript, please refer to this resubmission checklist: https://plos.io/Biology_Checklist

To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record.

Please make sure to read the following important policies and guidelines while preparing your revision:

*Published Peer Review*

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

*PLOS Data Policy*

Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5

*Blot and Gel Data Policy*

We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Best wishes,

Ines

--

Ines Alvarez-Garcia, PhD,

Senior Editor,

ialvarez-garcia@plos.org,

PLOS Biology

---------------------------------------------------------------

Reviewers’ comments

Rev. 1:

In this manuscript, Brügger et al. characterize the epithelial and mesenchymal/fibroblast populations of the mouse colon using sc-RNAseq. They compare this to the human colon cell populations and find they are quite comparable. The story is descriptive (which I do not intend to sound like a bad thing) and results in the identification of three different populations of fibroblasts: two associated with the bottom of the crypt (CBF1 and CBF2) and one associated with the top of the crypt (CTF). These populations express different signaling factors that either promote stemness (CBF: Wnt2, Wnt2b and Rspo3) or differentiation (CTF: Wnt5a and Bmps). The authors also provide evidence that these populations correspond to spatially separated Pdgrfa+ populations in situ (Pdgrfa-high: CTF, low: Pdgrfa-CBF1 and 2).

The manuscript is clearly written, with a balanced and focused introduction. The dataset (>7000 cells total, >3000 transcripts per cell) has been deposited at NCBI GEO and promises to be a useful resource for scientists interested in the interaction between intestinal stem cells and their presumed niche.

This is a straightforward study and I only have a few remarks that perhaps the authors can consider to clarify a few points:

1. The introduction mentions that most other studies use specific cell isolation protocols. It is not clear what the authors refer to, given that they themselves of course also use an enzymatic digestion and cell isolation protocol (i.e. FACS sort for EPCAM+ and EPCAM- cells). I think I get what they mean (theirs is 'just' a sort for epithelial versus non-epithelial), rather than a specific enrichment for a subpopulation, but perhaps they can clarify this a bit.

2. In Figure 1B, does this refer to the input prior to sorting or is this purity after sorting?

3. Related to the sorting: Can the authors comment on and/or quantify the ratio of these different cell populations (CBF1/2 vs CTF vs epithelial cells)?

4. Figure 2 and throughout: Can the authors speculate on the difference between the CBF1 and CBF2 population? Are there any discriminatory marks that separate these two otherwise functionally overlapping populations? Based on 2G this seems a logical step to include in this manuscript and something the authors should be able to do with the tools and analysis pipeline at hand, or is this something the authors plan to follow up on later? Alternatively, could it be some sort of experimental artifact? A list of differentially expressed genes in these populations might be informative.

5. From the legend of Figure 3A-C it is not clear that we are looking at cryosections, but I imagine that this is what is depicted, based on the methods?

6. Related to 5: Has the GFP signal been corrected for DAPI? The authors describe in the methods how they performed the GFP quantification, but this seems to related to masking of nuclei to include. Ideally, the GFP signal is corrected for the DAPI intensity to make up for depth/sectioning/processing/imaging differences at different locations on the slide. If it is not done or cannot be done, this should be noted in the legends and/or methods.

Rev. 2: Shalev Itzkovitz – this reviewer has waived anonymity

In this work, Brugger et al. perform single cell RNAseq experiments to characterize the mesenchymal cell types constituting the colonic crypt niche. They uncover three distinct Pdgfra+ fibroblast populations, expressing distinct antagonistic morphogens. More specifically, crypt bottom fibroblasts, which express canonical Wnt ligands, Rspo3 and Bmp inhibitors, and crypt top fibroblasts, expressing non-canonical Wnt ligands and Bmp ligands. The study is well performed and will be an important resource for biologists interested in stem cell biology. The following points should be addressed in a revision:

- The supplementary figures nicely show the expression of ligands of major signaling pathways among the three fibroblast populations, however the paper would be strengthened by a more comprehensive analysis of ligand-receptor interactions, most importantly between the fibroblasts and epithelial compartments. Specifically, what are the main elevated epithelial ligands expressed in tip/crypt enterocytes with matching elevated tip/crypt fibroblast receptors and vice versa? There are several examples, e.g. Pdgfra in the crypt tip enterocytes and Pdgfra in the CTF, Rspo3 in CBF and matching epithelial receptor Lgr5 at the crypt bottom. Such analysis can be performed by tools such as https://www.cellphonedb.org/ or NicheNet (https://www.nature.com/articles/s41592-019-0667-5). Similarly, are there interactions between the fibroblast populations and pericytes/endothelial clusters?

- Can the authors comment about the potential spatial differences between CBF1 and CBF2? Is one population closer to the epithelium? Do any of these populations overlap trophocytes (https://www.nature.com/articles/s41556-020-0567-z)?

- Do CTFs express Lgr5, as has been shown for villus tip telocytes (VTTs, ref 20)? The authors should comment on the overlap and differences in gene expression between CTFs and VTTs, which express many of the discussed CTF markers, such as the non-canonical Wnt5a, Bmp ligands and F3.

- It would be informative to add immunofluorescence for PDGFRA protein, which labels the entire cell bodies. Telocytes have a unique morphology with elongated processes that 'wrap around' the crypts, as well as tiny 'telopode' protrusions into the lamina propia, such staining for PDGFRA would reveal such morphologies in the colon.

- The expression of both the canonical Wnt ligands and antagonists is intriguing, do the same CBF cells express both ligands and antagonists, or are they expressed in different CBF subsets?

- Row 213 - add ref for the connection between the Lef1 regulon and Lgr5 expression.

- Row 406 - add ref. for "McCarthy and colleagues"

Rev. 3:

Summary of opinion: The instructions to the reviewer start "Short Reports should be novel, provocative and of general interest". The findings here are of general interest and high quality. They are not particularly novel, and because they support and extend prior studies, they are only modestly provocative. Overall, this manuscript contributes to the research field of scRNAseq and stem cell regulation, revealing the heterogeneous cell populations that regulate cellular homeostasis in the colon. Given the useful and high quality confirmatory, rather than novel, nature of the manuscript, I defer to the editor to decide if it meets the journal's editorial guidelines.

General comments: Brügger et al. aim to identify mesenchymal cell populations regulating proliferation and differentiation of colonic stem cells located in the crypt base. To look into the heterogenous nature of the intestinal mesenchymal tissue, scRNAseq was performed. The authors identified three distinct PDGFRA positive fibroblast subpopulations expressing Wnt or Bmp signals that regulate stem cell fate.

Generally, the setup of experiments is comprehensible and the authors present their data in a logic and conclusive way. The experiments and the interpretation of the data appear reliable and solid. The cell number (7395) and the read depth (3243/cell) is robust and will be a useful resource.

However, in a recent study published by McCarthy and colleagues (and cited appropriately) nearly identical results were presented. Here, a very similar experimental setup was used to identify mesenchymal cell populations regulating stem cells in the small intestine. McCarthy et al found the same cell populations with very similar gene expression profiles and localizations within the intestinal tissue. Therefore, this study by Brüegger et al has largely a confirmative character, since it reflects and verifies the results of the study from McCarthy and colleagues and doesn't break much new ground.

Additionally, by reanalysis of a recently published dataset, Brüegger et al could show that similar cell populations exist in human colonic tissue what might make this study useful for researchers focused on tumor initiation and progression.

Overall, this manuscript contributes to the research field of stem cell regulation revealing the heterogeneous cell populations which fulfil the regulation of the sensitive cellular homeostasis in the colon.

Major points:

CBF1 and CBF2 were shown to represent 2 distinct cell populations. However, the authors did not show data about the spatial localization of both cell types within the tissue.

Are both CBF1 and 2 needed to support stem cell growth? Or can this be achieved by only CBF1 or CBF2? Organoids would be a suitable model to examine this issue. According to the title, CBFs act as hubs to control colon homeostasis, what is not reflected in the experimental results.

Line 401: The statement "Canonical Wnt ligands, which are integral to intestinal epithelial stem cell maintenance, are secreted by epithelial Paneth cells in the small intestine" is misleading and should be corrected. Multiple studies from multiple labs have shown that Paneth cells, Wnt3 in intestinal epithelium, and Porcn and Wls in the intestinal epithelium are all completely dispensable for normal small intestine function.

Minor points:

Page 5, line 100: non-epithelial (EpCAM-, CD45+) cells should be ***CD45-*** cells

Page 6, line 132: Dll1 and Dll4 expression is displayed in S1D not S1C

Page 6, line 135: GO-terms are shown in S1C not S1D

Page 6, line 137" Egf family ligands and ephrins expression can be found in S1D not S1C

Page 7, line 139: Ihh expression is shown in S1D not S1C

Sometimes the reference to the figures is missing in the text, what makes it difficult for the reader to follow the results, e.g.

- page 6, line 127: Lgr5, Olfm4, Axin2 and Mki67. Moreover, Olfm4 and Mki67 expression is not displayed in the figures

- page 6, line 133: (Guaca2a+, Alpi+, Aldh1/1+)

Page 8, line 183: S1 and S1 should be S2

Page 10, line 233: Expression of Vimentin cannot be found in Fig. S3A

Decision Letter 2

Ines Alvarez-Garcia

13 Nov 2020

Dear Tomas and Konrad,

Thank you for submitting your revised Short Reports entitled "Distinct populations of crypt-associated fibroblasts act as signaling hubs to control colon homeostasis" for publication in PLOS Biology. I have now discussed your revision with the team of editors and obtained advice from the Academic Editor.

We're delighted to let you know that we're now editorially satisfied with your manuscript. However before we can formally accept your paper and consider it "in press", we also need to ensure that your article conforms to our guidelines. A member of our team will be in touch shortly with a set of requests. As we can't proceed until these requirements are met, your swift response will help prevent delays to publication. Please also make sure to address the data and other policy-related requests noted at the end of this email.

To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following:

- a cover letter that should detail your responses to any editorial requests, if applicable

- a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable)

- a track-changes file indicating any changes that you have made to the manuscript.

*Copyediting*

Upon acceptance of your article, your final files will be copyedited and typeset into the final PDF. While you will have an opportunity to review these files as proofs, PLOS will only permit corrections to spelling or significant scientific errors. Therefore, please take this final revision time to assess and make any remaining major changes to your manuscript.

NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:

https://journals.plos.org/plosbiology/s/supporting-information

*Published Peer Review History*

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

*Early Version*

Please note that an uncorrected proof of your manuscript will be published online ahead of the final version, unless you opted out when submitting your manuscript. If, for any reason, you do not want an earlier version of your manuscript published online, uncheck the box. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods

Please do not hesitate to contact me should you have any questions.

Best wishes,

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor,

ialvarez-garcia@plos.org

PLOS Biology

------------------------------------------------------------------------

ETHICS STATEMENT:

-- Thank you for sending us the details of the ethics permit. Please include the use protocol/permit/project license.

------------------------------------------------------------------------

DATA POLICY: IMPORTANT - PLEASE READ

You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797

Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms:

1) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as 'Supporting Information' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore).

2) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication.

Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it:

Fig. 1B; Fig. 2C, D; Fig. 3D, E; Fig. 4C, D and Fig. S4C

NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values).

Please also ensure that figure legends in your manuscript include information on WHERE THE UNDERLYING DATA CAN BE FOUND, and ensure your supplemental data file/s has a legend.

Please ensure that your Data Statement in the submission system accurately describes where your data can be found.

Also, please make available the data that you have deposited in GEO with the accession number GSE151257

Decision Letter 3

Ines Alvarez-Garcia

25 Nov 2020

Dear Dr Valenta,

On behalf of my colleagues and the Academic Editor, Emma Rawlins, I am pleased to inform you that we will be delighted to publish your Short Reports in PLOS Biology.

PRODUCTION PROCESS

Before publication you will see the copyedited word document (within 5 business days) and a PDF proof shortly after that. The copyeditor will be in touch shortly before sending you the copyedited Word document. We will make some revisions at copyediting stage to conform to our general style, and for clarification. When you receive this version you should check and revise it very carefully, including figures, tables, references, and supporting information, because corrections at the next stage (proofs) will be strictly limited to (1) errors in author names or affiliations, (2) errors of scientific fact that would cause misunderstandings to readers, and (3) printer's (introduced) errors. Please return the copyedited file within 2 business days in order to ensure timely delivery of the PDF proof.

If you are likely to be away when either this document or the proof is sent, please ensure we have contact information of a second person, as we will need you to respond quickly at each point. Given the disruptions resulting from the ongoing COVID-19 pandemic, there may be delays in the production process. We apologise in advance for any inconvenience caused and will do our best to minimize impact as far as possible.

EARLY VERSION

The version of your manuscript submitted at the copyedit stage will be posted online ahead of the final proof version, unless you have already opted out of the process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

Thank you again for submitting your manuscript to PLOS Biology and for your support of Open Access publishing. Please do not hesitate to contact me if I can provide any assistance during the production process.

Kind regards,

Erin O'Loughlin

Publishing Editor,

PLOS Biology

on behalf of

Ines Alvarez-Garcia,

Senior Editor

PLOS Biology

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Interrogation of the colonic epithelium reveals a variety of known and unknown growth factors.

    (A) Cell numbers of the particular clusters indicated in Fig 1C. (B) Heatmap of genes that are differentially expressed among the epithelial clusters (0.97 quantile), reveals heterogeneity between and similarity within the major epithelial lineages (stem-/transit-amplifying-, secretory-, absorptive-, enteroendocrine cells). (C) Relative expression of epithelial signaling pathway components. (Dot plot, size, and color of the dot represent the percentage of cells which express the transcript and the average expression level within a cluster, respectively). (D) GO enrichment terms for Enterocyte 1. GO, Gene Ontology.

    (TIF)

    S2 Fig. Growth factors produced by colonic mesenchymal cells.

    (A) GO enrichment terms for SMC. (B) Relative expression of factors involved in WNT, BMP, and RTK/MAPK pathways. (Dot plot, size, and color of the dot represents the percentage of cells which express the transcript and the average expression level within a cluster, respectively). (C) GO enrichment terms for CBFs 1. (D) GO enrichment terms for CBFs 2. (E) Heatmap showing the specific enrichment for transcription factor regulon activity in specific stromal clusters (scaled regulon activity, SCENIC). Bmp, bone morphogenetic protein; CBF, crypt-bottom fibroblast; GO, Gene Ontology; MAPK, mitogen-activated protein kinase; RTK, receptor tyrosine kinase; SCENIC, single-cell regulatory network inference and clustering; SMC, smooth muscle cell.

    (TIF)

    S3 Fig. Interactome of colonic mesenchymal cells.

    (A) Putative ligand–receptor interactions between CBFs1, CBFs2, CTFs, and colonic epithelial subpopulations. Size of the dots represents the significance of the interaction, and color shows the expression of the ligand and receptor in the interacting cell types (CellphoneDB). (B) Density of Wnt2, Wnt2b, Cd81, Grem1, and Rspo3 expressing cells. (UMAP, color indicates the density of cells expressing transcript). CBF, crypt-bottom fibroblast; CTF, crypt-top fibroblast; UMAP, Uniform Manifold Approximation and Projection.

    (TIF)

    S4 Fig. Fibroblast identity of CTFs and CBFs.

    (A, B) Cryosections of Pdgfra-H2B-eGFP mice (A) and Pdgfra-CreERT2; LSL-tdTomato mice (B). (A) Vimentin expression (red) in Pdgfra+ cells (green) on representative Pdgfra-H2B-eGFP colonic tissue sections confirms their fibroblast identity. (Scale bar = 40 μm) (1,2) Insets of crypt top and crypt bottom, respectively (Scale bar = 5 μm). (B) Pdgfra-CreERT2; LSL-tdTomato lineage tracing (single tamoxifen injection, 1 d.p.i.) reveals morphology of Pdgfra-expressing cells, tdTomato (white) (Scale bar = 10 μm) (C) Flow cytometry analysis for GFP of a mesenchymal single-cell suspension isolated from Pdgfra-H2B-eGFP mice. (Raw data: S5 Data) (D, E) Relative expression of Pdgfra (D) and colonic niche factors (E) in Pdgfra+ colonic mesenchymal cells. (UMAP, single cells are colored according to transcript expression). CBF, crypt-bottom fibroblast; CTF, crypt-top fibroblast; d.p.i., days post injection; Pdgfra, platelet-derived growth factor receptor A; UMAP, Uniform Manifold Approximation and Projection.

    (TIF)

    S5 Fig. Interspecies conservation of colonic mesenchymal subpopulations.

    (A) Heatmap showing the similarity (Jaccard index) of murine and human colonic mesenchymal subpopulations (matchSCore2).

    (TIF)

    S1 Data. This file contains the raw data for the indicated figures.

    (A) Transcript expression of Pdgfra for Fig 2C. (B) Transcript expression of Vim, Col1a1, Acta2, Myh11, Wnt2, Wnt2b, Rspo3, Grem1, Wnt5a, Bmp3, and Bmp7 for Fig 2D. (C) Numeric values and statistical analysis of the PdgfraEGFP fluorescence intensity quantification in Fig 3C. (D) Raw data and fold change calculation of the qPCR data shown in Fig 3E. (E) Transcript expression of PDGFRA for Fig 4C. (F) Transcript expression of WNT2B, WNT5A, RSPO3, BMP2, and GREM1 for Fig 4D. Bmp, bone morphogenetic protein; Pdgfra, platelet-derived growth factor receptor A; qPCR, quantitative polymerase chain reaction.

    (XLSX)

    S2 Data. FCS file containing the raw data of the FACS sorting of the epithelial cell isolation depicted in Fig 1B.

    FACS, fluorescence-activated cell sorting; FCS, flow cytometry standard.

    (FCS)

    S3 Data. FCS file containing the raw data of the FACS sorting of the mesenchymal cell isolation depicted in Fig 1B.

    FACS, fluorescence-activated cell sorting; FCS, flow cytometry standard.

    (FCS)

    S4 Data. FCS file containing the raw data of the FACS sorting of two populations (low and high) of PdgfraEGFP positive cells depicted in Fig 3D.

    FACS, fluorescence-activated cell sorting; FCS, flow cytometry standard.

    (FCS)

    S5 Data. FCS file containing the raw data of the FACS sorting for PdgfraEGFP positive cells depicted in S4C Fig.

    FACS, fluorescence-activated cell sorting; FCS, flow cytometry standard.

    (FCS)

    Attachment

    Submitted filename: PLOS_biology_Response_to_reviewers.pdf

    Attachment

    Submitted filename: PLOS_biology_Response_to_reviewers.pdf

    Data Availability Statement

    Single-cell RNA sequencing data generated in this study are deposited in GEO with the accession number GSE151257. All data needed to reproduce the figures in this publication can be found in the supporting information. The FACS sorting plots in Fig 1B, Fig 3D and S4C Fig are based on the .fcs data files in n S2 Data, S3 Data, S4 Data and S5 Data respectively. Transcript expression data for the violin plots in Fig 2C and 2D and Fig 4C and 4D can be found in S1A, S1B, S1E and S1F Data respectively. Fluorescence intensity measurements in Fig 3C and statistical analysis can be found in S1C Data. Raw data for the qPCR data in Fig 3E can be found in n S1D Data.


    Articles from PLoS Biology are provided here courtesy of PLOS

    RESOURCES